Search
  1. Home
  2. East Africa
  3. Rwanda
  • News

Ambitious ARV rollout plan announced

    JOHANNESBURG

    US pharmaceutical company Merck, Sharp and Dohme (MSD) is to help Rwanda increase the number of HIV-positive people receiving anti-AIDS treatment.

    MSD resident representative Dr Dominique Gacukuzi said a collaborative effort between the government of Rwanda and his firm aimed to grant 100,000 people access to antiretroviral (ARV) drugs by 2007 at various district hospitals.

    The local New Times newspaper quoted Gacukuzi as saying, "Our goal is to help Rwanda to expand HIV/AIDS care with adequate management of treatment, including administering of ARVs at both primary and secondary levels of care."

    Over the past year Rwanda has tripled the number of people on ARVs to approximately 13,250 - about 20 percent of the total number of Rwandans who need it.

    This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

    Share this article

    Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

    We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

    Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

    Become a member of The New Humanitarian

    Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

    Join